Cargando…
MicroRNA signatures and Foxp3(+) cell count correlate with relapse occurrence in follicular lymphoma
First line drug treatment of follicular lymphoma (FL) patients is followed by a highly variable disease-free time before relapse in about one third of patients. No molecular marker is able to predict efficiently the risk of relapse. We investigated the expression profile of microRNAs (miRNAs) by mic...
Autores principales: | Malpeli, Giorgio, Barbi, Stefano, Greco, Corinna, Zupo, Simonetta, Bertolaso, Anna, Scupoli, Maria Teresa, Krampera, Mauro, Kamga, Paul Takam, Croce, Carlo Maria, Scarpa, Aldo, Zamò, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929439/ https://www.ncbi.nlm.nih.gov/pubmed/29731996 http://dx.doi.org/10.18632/oncotarget.24987 |
Ejemplares similares
-
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways
por: Malpeli, Giorgio, et al.
Publicado: (2018) -
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53
por: Malpeli, Giorgio, et al.
Publicado: (2017) -
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia
por: Cavallini, Chiara, et al.
Publicado: (2015) -
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells
por: Cavallini, Chiara, et al.
Publicado: (2013) -
Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells
por: Bazzoni, Riccardo, et al.
Publicado: (2020)